Share on StockTwits

Shares of Envision Healthcare Holdings (NASDAQ:EVHC) have been given a consensus rating of “Buy” by the eighteen brokerages that are currently covering the company, AR Network reports. Three investment analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $49.20.

In other Envision Healthcare Holdings news, major shareholder Associates Viii Ltd. Cd&R sold 30,250,843 shares of Envision Healthcare Holdings stock on the open market in a transaction dated Wednesday, July 16th. The stock was sold at an average price of $32.90, for a total value of $995,252,734.70. The transaction was disclosed in a filing with the SEC, which is available at this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Shares of Envision Healthcare Holdings (NASDAQ:EVHC) traded up 1.30% on Wednesday, hitting $35.98. 213,601 shares of the company’s stock traded hands. Envision Healthcare Holdings has a 1-year low of $24.62 and a 1-year high of $38.02. The stock has a 50-day moving average of $35.5 and a 200-day moving average of $34.01. The company has a market cap of $6.517 billion and a P/E ratio of 174.98.

Envision Healthcare Holdings (NASDAQ:EVHC) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.01. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the previous year, the company posted ($0.03) earnings per share. The company’s revenue for the quarter was up 14.2% on a year-over-year basis. On average, analysts predict that Envision Healthcare Holdings will post $1.13 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Wells Fargo & Co. initiated coverage on shares of Envision Healthcare Holdings in a research note on Wednesday, July 23rd. They set a “market perform” rating on the stock. Separately, analysts at Deutsche Bank raised their price target on shares of Envision Healthcare Holdings from $37.00 to $41.00 in a research note on Tuesday, July 22nd. They now have a “buy” rating on the stock. Finally, analysts at Robert W. Baird initiated coverage on shares of Envision Healthcare Holdings in a research note on Wednesday, July 9th. They set an “outperform” rating and a $42.00 price target on the stock.

Envision Healthcare Holdings, Inc, is a provider of physician-led, outsourced medical services in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.